[Clinical features and viral markers in patients with chronic hepatitis positive for both HBs antigen and anti-C-100 antibody].
Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Tsuto MORINAGA, Yasunari Sakai(Kyushu University), Shinobu Saito, Midori Kobayashi(FIND), H Kumada(Toranomon Hospital), Takao Matsumoto(Shizuoka City Hospital), Yoshitaka Arase(Tokai University), Kiyoshi Ikeda
PubMed
September 1, 1991
Cited by 1
Related Papers
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
|Nature Genetics|2009|523
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.
|Proceedings of the National Academy of Sciences|1987|253